Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
More Monday ONCX ignorance........
The Company believes that it has sufficient cash on hand to fund its operations into April 2018, before the time when the first installment for repayment of our Convertible Notes become due. The exact duration that our liquidity will be sufficient to fund operations depends upon many factors, some of which are outside the control of the Company and is difficult to predict. We expect our research and development expenses to increase in connection with our ongoing activities relating to Prolanta™, particularly as we focus on and proceed with our clinical trials for our Prolanta™ product. In addition, our expenses could increase beyond current expectations if applicable regulatory authorities, including the FDA, require that we perform studies in addition to those that we currently anticipate, assuming we successfully complete our Phase 1 clinical trials, commence and complete our proposed Phase 2 clinical trials. We currently estimate that we require approximately $1.0 million in additional funds to complete the Phase 1 clinical trial, excluding amounts that may be necessary for payment of interest and principal of our Convertible Notes when due. We will still need substantial additional capital in the future in order to complete the clinical trials and obtain regulatory approval of Prolanta™. Accordingly, we will need to raise additional capital to fund future operations and we expect to finance future cash needs
through best-efforts public or private equity offerings, debt financings or corporate collaboration and licensing arrangements. Such funding may not be available on favorable terms, if at all. Failure to raise additional capital could cause us to curtail or cease operations and result in the loss of your investment in our Common Stock.
10K 3/14/18 Page 22
Maybe Redscam felt guilty and is using some of the $300,000 salary he skimmed from investors last year to attend the conference....lol
A "blind ask" refers to buying ONCX stock. An investor has to be deaf, dumb, and blind to buy such a pos....lol
Good thing Mike Wallace from 60 Minutes is no longer alive. He would've had a field day with the corruption, lies, and shareholder manipulation ONCX has shown over the past year.
LOL...correction, you may not have ever claimed this but there were many others that did.
Most recent presentation will soon be modified or more likely removed from the Oncolix website. This definitely should be brought to the attention of the SEC.
60 Minutes would have a field day with ONCX.....LOL
Yep, wrestling an enormous amount of shares away from people....10,500 today alone.....LOL
Lots of cheapies soon. August right around the corner...lol
"Additionally, there are 63,038,284 shares of Series A Preferred Stock that are currently convertible into 66,872,296 shares of Common Stock eligible to be resold pursuant to Rule 144 commencing in August 2018. In addition, upon the exercise of warrants to acquire Series A Preferred Stock or the exercise of other warrants and options to acquire Common Stock, 65,773,896 shares of Common Stock could be issued and become eligible to be resold pursuant to Rule 144 commencing in August 2018."
Source 424B3 Filed 2/9/2018
Really????? The carnage is hardly over and pps is still down from what it was market close Tuesday and new base is approaching .03......LOL
Happens every year on March 2nd....lol
News of continued dosing !!!!!!!!!!!!!!!!!!!!!!!!!!!!
may never be released
Wow!!! Another major investor working out of his house or god knows where...lol
News of continued dosing!!!!!!!!!!!
Don't kid yourselves. Wen Chen is NOT associated with Oncolix anymore...lol
Dream on...lol
Not compensated now, but compensated soon. Where will the $$$$ will come from to compensate directors in the future if no revenue...lol
Texas Treasury is chomping at the bit to unload their 59,776,909 shares once August 2018 arrives....lol
Less than 6 months to go before August 2018.
63,038,284 shares of Series A Preferred Stock that are currently convertible into 66,872,296 shares of Common Stock eligible to be resold pursuant to Rule 144 commencing in August 2018.
In addition, upon the exercise of warrants to acquire Series A Preferred Stock or the exercise of other warrants and options to acquire Common Stock, 65,773,896 shares of Common Stock could be issued and become eligible to be resold pursuant to Rule 144 commencing in August 2018.
Anybody know about Rule 144? You will soon hear more about it as it will come into play August 2018....lol
"Rule 144 will not be available until August 2018 and this may affect trading in our stock before and after this date.
As a result of the Merger, AEPP ceased being a “shell” company under the SEC’s rules and Rule 144 will be available commencing in August 2018. The unavailability of Rule 144 until August 2018 may impact the trading market for the Company Common Stock prior to and after August 2018.
A significant portion of our total outstanding shares are restricted from immediate resale but may be sold into the market in the near future, which could cause the market price of our Common Stock to drop significantly, even if our business is doing well.
Sales of a substantial number of shares of our Common Stock in the public market could occur at any time, either from holders of shares that are in the public float or as a result of registering the issuance of shares to be issued upon conversion of the Convertible Notes and exercise of the Warrants. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our Common Stock. As of this date, there are approximately 103,878,536 shares of Common Stock outstanding. Of such number, approximately 31,765,903 shares may be sold in the public market immediately without restriction and the balance are currently restricted as a result of securities laws or lock-up agreements until at least August 2018. Additionally, there are 63,038,284 shares of Series A Preferred Stock that are currently convertible into 66,872,296 shares of Common Stock eligible to be resold pursuant to Rule 144 commencing in August 2018. In addition, upon the exercise of warrants to acquire Series A Preferred Stock or the exercise of other warrants and options to acquire Common Stock, 65,773,896 shares of Common Stock could be issued and become eligible to be resold pursuant to Rule 144 commencing in August 2018.
Source 424B3 Filed 2/9/2018
To make matters worse, where did $$$$$ come from to attend conferences????? Redscam didn't stay at a Motel 6.....lol
September 26, 2017 - $$$$$$$$$$$$$$$$$
RESI - Boston
October 5, 2017 - $$$$$$$$$$$$$$$$$
The MicroCap Conference - New York City
November 6 to 8, 2017 - $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
BIO Europe - Berlin, Germany
January 9, 2018 - $$$$$$$$$$$$$$$$$$$$$$
RESI - San Francisco
January 8 to 11, 2018 - $$$$$$$$$$$$$$$$$$$$$$
JP Morgan - San Francisco
Natives getting restless...lol. Redscam will remain tight-lipped and will not release any news or a PR that will send the pps up until it's close to the time all those shares he and the others own will become unlocked. Gotta a long time to wait shareholders.
Lol Reapy, never stated Redscam could pay himself a salary anytime he wanted to. Again here is my post you replied to in case you need to read it again:
You are kidding me right? Can you run that board of directors approval BS by me again....lol. The board of directors are all Redscam's childhood friends and associates, why wouldn't they approve????????
Redscam gets paid 100% of his salary and 0% is deferred in 2017, for accomplishing what????? Owning a private company and taking it public???? That's all he accomplished in 2017. Sounds like I'm starting a new career if it's that easy to make $300,000....lol
2/9/2018 424B3:
"The base salary of Mr. Redman was $290,016 for the periods noted. A variable percentage of salary was paid each period depending on the available cash resources of the Company, and the remainder was deferred. During 2017, $290,016 was paid in cash and $0 was deferred. During 2016, $99,254 was paid in cash and $190,762 was deferred. Mr. Redman has agreed to defer payment of the unpaid amounts for these and prior years until such time as the Company has raised additional funds, and these unpaid amounts are reflected as deferred compensation in the Company’s financial statements."
11/30/2017 424B3:
"The base salary of Mr. Redman was $290,016 for the periods noted. A variable percentage of salary was paid each period depending on the available cash resources of the Company, and the remainder was deferred. During 2016, $99,254 was paid in cash and $190,762 was deferred. During 2015, $145,008 was paid in cash, and $145,008 was deferred. Mr. Redman has agreed to defer payment of the unpaid amounts for these and prior years until such time as the Company has raised additional funds, and these unpaid amounts are reflected as deferred compensation in the Company’s financial statements."
It's a CEO's dream when he hears stockholders state "So what he only took 300,000, Is he suppose to work for free". Redscam has you in the palm of his hands!!!!
Oh how true and finally someone with some common sense posts something that puts it all in perspective. All it would take is for Redscam to release a PR with all of those questions answered, but you will never see one...lol.
Sugarcoating....lol. Should have stated that much prior to 2017 has been deferred. Now that ONCX is public, Redscam deferring his salary will be a thing of the past....oh, and just wait until Redscam feels the need to pay himself back for all those years that were deferred and can easily do it now that he has deeper pockets thanks to all you shareholders who believe this has "potential"...lol
The year the company goes public, Redscam gets paid 100% of his salary and 0% is deferred. Prior to that, not so. Why?????????? It was all part of the plan to go public and the ease of which to have the $$$$ available to do so that bothers me and IMO to take advantage of shareholders.
2/9/2018 424B3:
"The base salary of Mr. Redman was $290,016 for the periods noted. A variable percentage of salary was paid each period depending on the available cash resources of the Company, and the remainder was deferred. During 2017, $290,016 was paid in cash and $0 was deferred. During 2016, $99,254 was paid in cash and $190,762 was deferred. Mr. Redman has agreed to defer payment of the unpaid amounts for these and prior years until such time as the Company has raised additional funds, and these unpaid amounts are reflected as deferred compensation in the Company’s financial statements."
11/30/2017 424B3:
"The base salary of Mr. Redman was $290,016 for the periods noted. A variable percentage of salary was paid each period depending on the available cash resources of the Company, and the remainder was deferred. During 2016, $99,254 was paid in cash and $190,762 was deferred. During 2015, $145,008 was paid in cash, and $145,008 was deferred. Mr. Redman has agreed to defer payment of the unpaid amounts for these and prior years until such time as the Company has raised additional funds, and these unpaid amounts are reflected as deferred compensation in the Company’s financial statements."
You're right, things are just getting started....another $300,000 salary paid to Redscam this year without producing any revenue, empty promises, more dilution, a change in the board of directors, delays in manufacturing Prolanta, yatta, yatta, yatta, yatta, yatta, yatta, yatta....
Just to put this in perspective, $300,000 paid to Redscam in 2017 is the equivalent of 7,500,000 shares at the current pps of .04....lol. Feel sorry for all of the investors who contributed millions of dollars and so sad for cancer victims hopeful that this company would someday find a cure for cancer.
Comical that a CEO of a worthless debt-ridden company with NO revenue would make an annual salary of $300,000,...lol. That's by far a higher salary than most any occupation in the US...lol. Chief Executives average $194,350. Wow!!! What a great gig to have!!!
https://www.bls.gov/oes/2016/may/oes_nat.htm
$300,000 salary paid to Redscam in 2017 and no revenue??? THAT IS A FACT PER THE FILING YESTERDAY. Pretty laughable stuff going on here when you consider ONCX has no revenue.....lol. I find the amateur hour bafoonery of those who do not know what is going on here to be pretty entertaining. I'll just sit back with my bowl of popcorn and smile when this cancer scam goes bellyup soon...lol
Here's another pesky fact, Redman's salary is not deferred:
"During 2017, $290,016 was paid in cash and $0 was deferred. During 2016, $99,254 was paid in cash and $190,762 was deferred."
Where did $290,016 come from if the company has no revenue?????
Source:
https://www.otcmarkets.com/stock/ONCX/disclosure
424B3 Filed 2/9/2017
Rookie mistake reaper....Redscam can paint and fly under the radar all day long. He owns less than 10% of stock therefore no need for him to file Form 4’s when he paints.
Now that they have shifted gears from ovarian cancer, I am 99.9% sure they need to immediately repay the funds they received from the Susan G Komen fund because they recived those funds with an agreement that they would strictly be used for ovarian cancer treatment and not uterine cancer.